Complications | Observed % | P-value* | |||
LTT | CT | ||||
Total N | Complication N (%) | Total N | Complication N (%) | ||
Infection | 12 | 0 (0%) | 17 | 0 (0%) | - |
Decreased vision1) |
|
|
|
| - |
≤2 months | 12 | 3 (25.0%) | 17 | 4 (23.5%) | 1.000 |
>2 months | 12 | 0 (0%) | 17 | 0 (0%) | - |
Shallow A/C |
|
|
|
| - |
≤3 days | 12 | 2 (16.7%) | 17 | 1 (5.9%) | 0.553 |
>3 days | 12 | 0 (0%) | 17 | 0 (0%) | - |
Symptomatic hypotony | 12 | 0 (0%) | 17 | 0 (0%) | - |
Bleb Leakage |
|
|
|
| - |
≤6 weeks | 12 | 1 (8.3%) | 17 | 1 (5.9%) | 1.000 |
>6 weeks | 12 | 2 (16.7%) | 17 | 0 (0%) | 0.163 |
Encapsulated bleb | 12 | 2 (16.7%) | 17 | 4 (23.5%) | 0.510 |
Overhanging bleb | 12 | 1 (8.3%) | 17 | 1 (5.9%) | 0.665 |